An update and guidance on narrowband ultraviolet B phototherapy: A British Photodermatology Group Workshop Report

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 283-297

  Ibbotson, S H ^a   Bilsland, D ^b   Cox, N H ^c   Dawe, R S ^a   Diffey, B ^d   Edwards, C ^e   Farr, P M ^f   Ferguson, J ^a   Hart, G ^g   Hawk, J ^h   Lloyd, J ^f   Martin, C ⁱ   Moseley, H ^a   McKenna, K ^j   Rhodes, L E ^k   Taylor, D K ^l  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c CUMBERLAND INFIRMARY   (United Kingdom)

^d NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^e ROYAL GWENT HOSPITAL   (United Kingdom)

^f ROYAL VICTORIA INFIRMARY   (United Kingdom)

^g BRADFORD ROYAL INFIRMARY   (United Kingdom)

^h ST THOMAS HOSPITAL   (United Kingdom)

ⁱ GARTNAVEL ROYAL HOSPITAL   (United Kingdom)

^j BELFAST CITY HOSPITAL   (United Kingdom)

^k HOPE HOSPITAL   (United Kingdom)

^l GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

more..

Author keywords

British Photodermatology Group; Guidance; TL 01; Ultraviolet B; Update

Indexed keywords

CALCIPOTRIOL; COAL TAR; COLECALCIFEROL DERIVATIVE; DITHRANOL; ETRETINATE; METHOXSALEN; PSORALEN; TAZAROTENE; TOPICAL AGENT;

ALOPECIA AREATA; ATOPIC DERMATITIS; BALNEOTHERAPY; BLISTER; CARCINOGENICITY; CLINICAL TRIAL; CONFERENCE PAPER; CUTANEOUS T CELL LYMPHOMA; DOSIMETRY; ECZEMA; ERYTHEMA; ERYTHROPOIETIC PROTOPORPHYRIA; GRANULOMA ANNULARE; HUMAN; HYDROA VACCINIFORME; INTERMETHOD COMPARISON; LICHEN PLANUS; MYCOSIS FUNGOIDES; PHOTODERMATOSIS; PHOTOTHERAPY; PITYRIASIS RUBRA PILARIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURIGO; PRURITUS; PSORIASIS; RADIATION RESPONSE; SEBORRHEIC DERMATITIS; SKIN DISEASE; SPECTRAL SENSITIVITY; SUBCORNEAL PUSTULAR DERMATOSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO;

COMBINED MODALITY THERAPY; ECZEMA; GREAT BRITAIN; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PSORIASIS; RADIATION DOSAGE; SKIN DISEASES; SKIN NEOPLASMS; ULTRAVIOLET THERAPY; VITILIGO;

EID: 4544320431     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06128.x     Document Type: Conference Paper

References (133)

1. van Weelden H, de la Faille HB, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
2. Green G, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-6.
3. Karvonen J, Kokkonen E-L, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with Ingram regimen. Acta Derm Venereol (Stockh) 1989; 69: 82-5.
4. Larkö O. Treatment of psoriasis with a new UVB-lamp. Acta Derm Venereol (Stockh) 1989; 69: 357-9.
5. Bilsland D, Dawe RS, Diffey BL et al. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997; 137: 327-30.
6. Dawe RS. The Scottish Phototherapy and PUVA audit. In: Phototherapy in the Treatment of Skin Disease in Scotland. University of Glasgow, 2001; MD Thesis: 17-94.
7. Johnson BE. Phototherapy. In: The Physiology and Pathophysiology of the Skin (Jarett A, ed.). London: Academic Press, 1984; 2607-19.
8. Krutmann J, Morita A. Mechanisms of ultraviolet (UV) B and UVA phototherapy. J Invest Dermatol Symp Proc 1999; 4: 70-2.
9. Hönigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol 2001; 26: 343-50.
10. Fluhr JW, Gloor M. The antimicrobial effect of narrow-band UVB (313 nm) and UVA1 (345-440 nm) radiation in vitro. Photodermatol Photoimmunol Photomed 1997; 13: 197-201.
11. Hruza LL, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol 1993; 100: S35-41.
12. Beissert S, Schwarz T. Role of immunomodulation in diseases responsive to phototherapy. Methods 2002; 28: 138-44.
13. Walters IB, Ozawa M, Carindale I et al. Narrowband (312 nm) UV-B suppresses interferon γ and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 2003; 139: 155-61.
14. Moodycliffe AM, Kimber I, Norval M. The effects of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology 1992; 77: 394-9.
15. Gibbs NK, Norval M, Traynor NJ et al. Comparative potency of broad-band and narrow-band phototherapy source to induce edema, sunburn cells and urocanic acid photoisomerization in hairless mouse skin. Photochem Photobiol 1993; 58: 643-7.
16. Guckian M, Jones CD, Vestey JP et al. Immunomodulation at the initiation of phototherapy and photochemotherapy. Photodermatol Photoimmunol Photomed 1995; 11: 163-9.
17. El-Ghorr AA, Norval M, Lappin MB, Crosby JC. The effect of chronic low dose UVB radiation on Langerhans cells, sunburn cells, urocanic acid isomers, contact hypersensitivity and serum immunoglobulins in mice. Photochem Photobiol 1995; 62: 326-32.
18. Jones CD, Guckian M, El-Ghorr AA et al. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 1996; 12: 204-10.
19. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B Biol 1997; 38: 99-106.
20. Fischer T. Comparative treatment of psoriasis with UV-light, trioxsalen plus UV-light, and coal tar plus UV-light. Acta Derm Venereol (Stockh) 1977; 57: 345-50.
21. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-62.
22. Dawe RS. A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis. Br J Dermatol 2003; 149: 669-72.
23. Storbeck K, Hölzle E, Schürer N et al. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227-31.
24. Coven TR, Burack LH, Gilleaudeau P et al. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broad-band UV-B. Arch Dermatol 1997; 133: 1514-22.
25. Gordon PM, Diffey BL, Matthews JNS, Farr PM. A randomised comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-32.
26. Cameron H, Dawe RS, Yule S et al. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 2002; 147: 973-8.
27. Dawe RS, Cameron H, Yule S et al. A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003; 148: 1194-204.
28. Dawe RS, Cameron H, Yule S et al. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071-6.
29. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis. Arch Dermatol 1999; 135: 519-24.
30. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993; 128: 49-56.
31. Collins P, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for atopic eczema in children. Br J Dermatol 1995; 133: 653-5.
32. Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996; 135: 332.
33. Grundmann-Kollmann M, Behrens S, Podda M et al. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999; 40: 995-7.
34. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000; 142: 39-43.
35. Reynolds N, Franklin V, Gray JC et al. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001; 357: 2012-16.
36. Wulf HC, Bech-Thomsen N. A UVB phototherapy protocol with very low dose increments as a treatment of atopic dermatitis. Photodennatol Photoimmunol Photomed 1998; 14: 1-6.
37. Legat FJ, Hofer A, Brabek E et al. Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003; 139: 223-4.
38. Pirkhammer D, Seeber A, Hönigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000; 143: 964-8.
39. Bilsland D, George SA, Gibbs NK et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-12.
40. Collins P, Ferguson J. Narrow-band UVB. (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132: 956-63.
41. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-8.
42. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment of vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
43. Tjioe M, Gerritsen MJP, Juhlin L, van de Kerkhof PCM. Treatment of vitiligo vulgaris with narrowband UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol (Stockh) 2002; 82: 369-72.
44. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-53.
45. Patel DC, Evans AV, Hawk JLM. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 2002; 27: 641-4.
46. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311 nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-80.
47. Clark C, Dawe RS, Evans AT et al. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 2000; 136: 748-52.
48. Gathers RC, Scherschun L, Malick F et al. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-7.
49. Diederen PVMM, van Weelden H, Sanders CJG et al. Narrow-band UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48: 215-19.
50. McGregor JM, Crook T, Fraser-Andrews EA et al. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999; 112: 317-21.
51. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re TL-01) vs. etretinate-PUVA (re PUVA) in the treatment of psoriasis. Br J Dermatol 1992; 127: 5-9.
52. Sakuntabhai A, Diffey BL, Farr PM. Response of psoriasis to psoralen-UVB photochemotherapy. Br J Dermatol 1993; 128: 296-300.
53. Ortel B, Perl S, Kinaciyan T et al. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 1993; 29: 736-40.
54. De Berker DAR, Sakuntabhai A, Diffey BL et al. Comparison of psoralen-UVB photochemotherapy in the treatment of psoriasis. J Am Acad Dermatol 1997; 36: 557-81.
55. Stege H, Reifenberger J, Bruch-Gerharz D et al. UVB-311 nm-Phototherapie in Kombination mit topischer Applikation von Tazaroten zur Behandlung der Psoriasis vulgaris. Z Hautkrank H+G 1998; 73: 708-9.
56. Behrens S, Grundmann-Kollmann M, Schiener R et al. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol 2000; 42: 493-5.
57. Brands S, Brakman M, Bos JS, de Rie MA. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol 1999; 41: 991-5.
58. Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 1993; 342: 923.
59. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CEM. Combination regimens of topical calcipotriene in chronic plaque psoriasis. Arch Dermatol 2000; 136: 1536-43.
60. 3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br J Dermatol 2001; 144: 628-9.
61. -1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. Br J Dermatol 2001; 144: 495-9.
62. Woo WK, McKenna KE. Combination TL-01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol 2003; 149: 146-50.
63. Léauté-Labrèze C, Saillour F, Chêne G et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B. Arch Dermatol 2001; 137: 1035-9.
64. Das S, Lloyd JJ, Farr PM. Similar dose-response and persistence of erythema with broad-band and narrow-band ultraviolet B lamps. J Invest Dermatol 2001; 117: 1318-21.
65. Picot E, Meunier L, Picot-Debeze MC et al. Treatment of psoriasis with 311 nm UVB lamp. Br J Dermatol 1992; 127: 509-12.
66. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998; 138: 833-9.
67. Wainwright NJ, Dawe RS, Ferguson J. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 1998; 139: 410-14.
68. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 1999; 140: 887-90.
69. George SA, Ferguson J. Lesional blistering following narrow-band (TL-01) UVB phototherapy for psoriasis: a report of four cases. Br J Dermatol 1992; 127: 445-6.
70. Calzavara-Pinton PG, Zane C, Candiago E, Facchetti F. Blisters on psoriatic lesions treated with TL-01 lamps. Dermatology 2000; 200: 115-19.
71. Khoo L, Asawanonda P, Grevelink SA, Taylor CR. Narrow-band UVB-associated lesional blisters in pityriasis rubra pilaris. J Am Acad Dermatol 1999; 41: 803-4.
72. Goodwin RG, Finlay AY, Anstey AV. Vitiligo following narrow-band TL-01 phototherapy for psoriasis. Br J Dermatol 2001; 144: 1264-5.
73. Perna JJ, Mannix ML, Rooney JF et al. Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model. J Am Acad Dermatol 1987; 17: 473-8.
74. Stanley SK, Folks TM, Fauci AS. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses 1989; 5: 375-84.
75. Beer JZ, Zmudzka BZ. Effects of UV on HIV and other infections. Introduction. Photochem Photomed 1996; 64: 231-3.
76. Morrey JD, Bourn SM, Bunch TD et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991; 65: 5045-51.
77. Beer JZ, Zmudzka BZ. UVB and PUVA therapies in HIV patients: are they safe? Photodermatol Photoimmunol Photomed 1997; 13: 91-2.
78. Meola T, Soter NA, Ostreicher R et al. The safety of UVB phototherapy in patients with HIV infection. J Am Acad Dermatol 1993; 29: 216-20.
79. Breuer-McHam J, Marshall G, Adu-Oppong A et al. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol 1999; 40: 48-60.
80. Johnston KJ, Oikarinen AI, Lowe NJ et al. Ultraviolet radiation-induced connective tissue changes in skin of hairless mice. J Invest Dermatol 1984; 82: 587-90.
81. Bissett DL, Hannon DP, Orr TV. Wavelength dependence of histological, physical, and visible changes in UV-irradiated hairless mouse skin. Photochem Photobiol 1989; 50: 763-9.
82. de Gruijl FR, van der Leun JC. Estimate of the wavelength dependency of ultraviolet carcinogenesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion. Health Phys 1994; 67: 319-25.
83. Oikarinen A, Karvonen J, Uitto J, Hannuksela M. Connective tissue alterations in the skin exposed to natural and therapeutic UV radiation. Photodermatology 1985; 2: 15-26.
84. Koivukangas V, Kalioinen M, Autio-Harmainen H, Oikarinen A. UV radiation induces the expression of gelatinases in human skin in vivo. Acta Derm Venereol (Stockh) 1994; 74: 279-82.
85. Larkö DY, Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol (Stockh) 1982; 62: 507-12.
86. Pittelkow MR, Perry HO, Muller SA et al. Skin cancer in patients with psoriasis treated with coal tar. Arch Dermatol 1981; 117: 465-8.
87. Stern RS, Zierler S, Parrish JA. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation. Lancet 1980; i: 732-5.
88. Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet-radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990; 322: 1093-7.
89. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994; 73: 2759-64.
90. Pasker-de Jong PCM, Wielink G, van der Valk PGM, van der Wilt G-J, Treatment with UV-B for psoriasis and non-melanoma skin cancer. Arch Dermatol 1999; 135: 834-40.
91. Slaper H, Schothorst AA, van der Leun JC. Risk evaluation of UVB therapy for psoriasis. Comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology 1986; 3: 271-83.
92. Tzung T-Y, Runger TM. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol 1998; 67: 647-50.
93. Budiyanto A, Ueda M, Ueda T, Ichihashi M. Formation of cyclobutane pyrimidine dimers and 8-oxo-7,8-dihydro-2′-deoxyguanosine in mouse and organ-cultured human skin by irradiation with broadband or with narrowband UVB. Photochem Photobiol 2002; 76: 397-400.
94. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol (Stockh) 1991; 71: 245-8.
95. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed 1994; 10: 192-7.
96. Gibbs NK, Traynor NJ, MacKie RM et al. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995; 104: 359-63.
97. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-2.
98. Man I, Crombie IK, Dawe RS, Ferguson J. The photocarcinogenic risk of narrowband TL-01 ultraviolet B phototherapy: early follow-up data. Br J Dermatol 2003; 149 (Suppl. 64): 12 (Abstract).
99. Niwa Y, Terashima T, Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 2003; 149: 960-7.
100. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998; 138: 96-100.
101. Walters IB, Burack LH, Coven TR et al. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1999; 40: 893-900.
102. Taylor DK, Anstey AV, Coleman AJ et al. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: a report of a British Photodermatology Group workshop. Br J Dermatol 2002; 146: 755-63.
103. Moseley H. Scottish UV dosimetry guidelines. Photodermatol Photoimmunol Photomed 2001; 17: 230-3.
104. Pye SD, Martin CJ. A study of the directional response of ultraviolet radiometers. I. Practical evaluation and implications for ultraviolet measurement standards. Phys Med Biol 2000; 45: 2701-12.
105. Martin CJ, Pye SD. A study of the directional response of ultraviolet radiometers. II. Implications for ultraviolet phototherapy derived from computer simulations. Phys Med Biol 2000; 45: 2713-29.
106. Lloyd JJ. Variation in calibration of hand-held UV meters for PUVA and narrowband UVB phototherapy. Br J Dermatol 2004; 150: 1162-6.
107. Martin CJ, Clouting H, Aitken A. A study of the correction factor of ultraviolet phototherapy dose measurements made by the indirect method. Br J Dermatol 2003; 149: 1227-31.
108. Currie GD, Evans AL, Smith D et al. An automated dosimetry system for testing whole-body ultraviolet phototherapy cabinets. Phys Med Biol 2001; 46: 333-46.
109. Fulljames CA, Welsh AD. Measurement of patient dose in ultraviolet therapy using a phantom. Br J Dermatol 2000; 142: 748-51.
110. Drummond A, Kane D, Bilsland D. Legal claims in Scottish National Health Service Dermatology Departments 1989-2001. Br J Dermatol 2003; 149: 111-14.
111. Cameron H, Dawe RS. Photosensitizing drugs may lower the narrow-band ultraviolet B (TL-01) minimal erythema dose. Br J Dermatol 2000; 142: 389-90.
112. Man I, Dawe RS, Ferguson J, Ibbotson SH. An intra-individual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband TL-01 UVB. Photochem Photobiol 2003; 78: 55-60.
113. Halasz CLG. Narrowband UVB phototherapy for psoriasis: results with fixed increments by skin type (as opposed to percentage increments). Photodermatol Photoimmnuol Photomed 1999; 15: 81-4.
114. Leenutaphong V, Nimkulrat P, Sudtim S. Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis. Photodermatol Photoimmunol Photomed 2000; 16: 202-6.
115. Diffey BL. Factors affecting the choice of a ceiling on the number of exposures with TL-01 ultraviolet B phototherapy. Br J Dermatol 2003; 149: 428-30.
116. Cameron H, Yule S, Moseley H et al. Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service. Br J Dermatol 2002: 147: 957-65.
117. Hofmann U, Ogilvie P, Hamm H et al. Schmalspektrum-UVB versus konventionelles Breitspektrum-UVB in Kombination mit Teer: ein Halbseitenvergleich bei 11 Patienten mit Psoriasis vulgaris. Akt Dermatol 1997; 23: 286-9.
118. van Weelden H, van der Leun JC. Improving the effectiveness of phototherapy for psoriasis. Br J Dermatol 1984; 111: 484 (Abstract).
119. Barth E, Pinzer B. Therapie der Psoriasis mit dem UV-Strahler Philips TL-01. Dermatol Monatsschr 1990; 176: 707-10.
120. van Weelden H, de la Faille HB, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol (Stockh) 1990; 70: 212-15.
121. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139: 325-8.
122. Yashar SS, Gielczyk R, Scherschun L, Lim HW. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed 2003; 19: 164-8.
123. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995; 190: 223-9.
124. Saricaoǧlu H, Karadogan SK, Başkan EB, Tunali S. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed 2003; 19: 265-7.
125. Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol 2002; 41: 282-3.
126. Cameron H, Dawe RS. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) treated with narrowband (TL-01) UVB phototherapy. Br J Dermatol 1997; 137: 150-1.
127. Orton DI, George SA. Subcorneal pustular dermatosis responsive to narrowband (TL-01) UVB phototherapy. Br J Dermatol 1997; 137: 149-50.
128. Wishart JM. Narrow-band UVB phototherapy: nine months' study in a New Zealand practice. Clin Exp Dermatol 1998; 23: 140-1.
129. Assouly P. Alopecia areata: update on therapy. Ann Dermatol Venereol 2002; 129: 831-6.
130. Bayramgürler D, Apaydin R, Çetiner D, Zincirci C. Narrow-band ultraviolet B phototherapy for acquired perforating dermatitis. Australas J Dermatol 2003; 44: 76-8.
131. Baldo A, Sammarco E, Plaitano R et al. Narrowband (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol 2002; 147: 979-81.
132. Warren LJ, George S. Erythropoietic protoporphyria treated with narrow-band (TL-01) UVB phototherapy. Australas J Dermatol 1998; 39: 179-82.
133. Holme SA, Mills CM. Crotamiton and narrow-band UVB phototherapy: novel approaches to alleviate pruritus of breast carcinoma skin infiltration. J Pain Symptom Manage 2001; 22: 803-5.